Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A congenital muscular dystrophy characterized by autosomal recessive inheritance of muscular dystrophy with variable penetrance of intellectual disability and structural brain abnormalities that has material basis in homozygous or compound heterozygous mutation in the FKRP gene on chromosome 19q13.3.
Features include always present findings: Elevated creatine kinase (muscle enzyme) (elevated circulating creatine kinase concentration), Proximal amyotrophy, Proximal muscle weakness, and Generalized muscle weakness; and very common findings: Low muscle tone (hypotonia). 42 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Muscles | 20 | Achilles tendon contracture, Shrinkage of the cerebellum (cerebellar atrophy), Difficulty climbing stairs |
Brain and nerves | 7 | Enlarged brain ventricles (ventriculomegaly), Intellectual disability, Difficulty swallowing (dysphagia) |
Bones and joints | 5 | Excessive inward curvature of the lower spine (hyperlordosis), Skeletal muscle atrophy, Sideways curvature of the spine (scoliosis) |
Head and neck | 3 | Facial palsy, Weakness of facial musculature, Microcephaly |
Lungs and breathing | 2 | Respiratory failure, Restrictive ventilatory defect |
Digestive system | 2 | Difficulty swallowing (dysphagia), Feeding difficulties |
Lab test results | 1 | Elevated creatine kinase (muscle enzyme) (elevated circulating creatine kinase concentration) |
Pregnancy and birth | 1 | Neonatal hypotonia |
Arms and legs | 1 | Tip-toe gait |
FKRP encodes fukutin related protein (495 aa). Catalyzes the transfer of a ribitol 5-phosphate from CDP-L-ribitol to the ribitol 5-phosphate previously attached by FKTN/fukutin to the phosphorylated O-mannosyl trisaccharide (N-acetylgalactosamine-beta-3-N-acetylglucosamine-beta-4-(phosphate-6-)mannose), a carbohydrate structure present in alpha-dystroglycan (DAG1). Highest expression in Pituitary (19.7 TPM) and Uterus (18.0 TPM).
Muscular dystrophy-dystroglycanopathy type B5 is associated with mutations in the FKRP gene on chromosome 19.
The FKRP protein participates in POMGNT1 catalyzes FKRP:FKTN:RXYLT1 formation and FKTN transfers RboP to GalNAc-GlcNAc-ManP-DAG1 pathways.
FKRP is classified as a druggable target (Druggable Genome category) with score 0.0.
Genetic testing for FKRP is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for muscular dystrophy-dystroglycanopathy type B5 has been reported in the published literature.
Phenotype severity distribution: 4 always present features, 1 very common feature, 6 common features.
No clinical trials have been registered for muscular dystrophy-dystroglycanopathy type B5.
114 publications have been identified in PubMed for muscular dystrophy-dystroglycanopathy type B5. Research spans Case Report / Case Series (26%), Basic Science / Preclinical (25%), and Epidemiology / Natural History (18%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 30 | 26% |
Laboratory research | 28 | 25% |
Disease patterns and progression | 20 | 18% |
Research summaries | 18 | 16% |
Testing and diagnosis research | 8 | 7% |
New treatment approaches | 6 | 5% |
Clinical study results | 3 | 3% |
Other research | 1 | 1% |
Lee CL (2026). [PMID: 41828661](https://pubmed.ncbi.nlm.nih.gov/41828661/). *Int J Mol Sci*. [Epidemiology / Natural History]
Moore D (2026). [PMID: 42619265](https://pubmed.ncbi.nlm.nih.gov/42619265/). *Mol Ther*. [Basic Science / Preclinical]
Faisal A (2026). [PMID: 42387640](https://pubmed.ncbi.nlm.nih.gov/42387640/). *J Med Case Rep*. [Case Report / Case Series]
Rossini E (2026). [PMID: 41251564](https://pubmed.ncbi.nlm.nih.gov/41251564/). *Muscle Nerve*. [Epidemiology / Natural History]
Caramizaru A (2026). [PMID: 41826152](https://pubmed.ncbi.nlm.nih.gov/41826152/). *Neuropathol Appl Neurobiol*. [Case Report / Case Series]
Kilicarslan OA (2026). [PMID: 41498167](https://pubmed.ncbi.nlm.nih.gov/41498167/). *Clin Genet*. [Case Report / Case Series]
Johari M (2026). [PMID: 41678358](https://pubmed.ncbi.nlm.nih.gov/41678358/). *Brain*. [Basic Science / Preclinical]
Hidalgo Mayoral I (2026). [PMID: 41022664](https://pubmed.ncbi.nlm.nih.gov/41022664/). *Clin Genet*. [Basic Science / Preclinical]
El-Hayek S (2026). [PMID: 41904993](https://pubmed.ncbi.nlm.nih.gov/41904993/). *J Neuromuscul Dis*. [Epidemiology / Natural History]
Lütkemeyer A (2026). [PMID: 41880120](https://pubmed.ncbi.nlm.nih.gov/41880120/). *Mol Biol Rep*. [Basic Science / Preclinical]
Data assembled from 6 of 12 sources · Last updated Sep 20, 2026, 5:49 AM UTC
Online Mendelian Inheritance in Man
European rare disease database